# US 2018/0024151 A1 · Mass spectrometric determination of eicosapentaenoic acid and docosahexaenoic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0024151 A1
- Document ID: US20180024151A1
- Status: Published application
- Kind: A1
- Application number: 15/635,509
- Filed: 2017-06-28
- Published: 2018-01-25
- Earliest claimed: 2010-09-16
- Assignees: Quest Diagnostics Investments Incorporated
- Applicants: Quest Diagnostics Investments Incorporated
- Inventors: Scott M. GOLDMAN; Julie A. NEIDICH
- Web page: https://patentgrep.com/patent/US20180024151A1

## CPC

- G01N 33/92: involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)}
- G01N 30/7266: {by electric field, e.g. electrospray}
- G01N 33/26: Oils; Viscous liquids; Paints; Inks (G01N33/22 takes precedence)
- H01J 49/0027: {Methods for using particle spectrometers}
- H01J 49/0031: {Step by step routines describing the use of the apparatus (H01J49/0081 takes precedence)}
- H01J 49/004: {Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn}
- H01J 49/165: {Electrospray ionisation}
- H01J 49/145: {using chemical ionisation}
- H01J 49/168: {field ionisation, e.g. corona discharge (atmospheric pressure corona discharge per se H01T19/00)}
- Y10T 436/104165: Lipid, cholesterol, or triglyceride standard or control
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- Y10T 436/25: including sample preparation
- Y10T 436/25125: Digestion or removing interfering materials
- Y10T 436/25375: Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T 436/255: including use of a solid sorbent, semipermeable membrane, or liquid extraction
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention relates to the detection of DHA and EPA. In a particular aspect, the invention relates to methods for detecting DHA and EPA by mass spectrometry and kits for carrying out such methods.

## Claims

### Claim 1

A method for determining the amount of one or more omega-3 fatty acids in a sample by mass spectrometry, the method comprising:
(i) ionizing said one or more omega-3 fatty acids from the sample to generate one or more ions detectable by mass spectrometry;
(ii) determining the amount of said one or more omega-3 fatty acids ions by mass spectrometry; and
(iii) relating the amount of DHA ions to the amount of one or more omega-3 fatty acids in the sample, wherein said one or more omega-3 fatty acids comprises docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA).

### Claim 2 (depends on 1)

The method of claim 1, wherein said ionizing comprises atmospheric pressure chemical ionization (APCI).

### Claim 3 (depends on 2)

The method of claim 2, wherein said APCI is in negative ionization mode.

### Claim 4 (depends on 1)

The method of claim 1, wherein said ionizing comprises electrospray ionization (ESI).

### Claim 5 (depends on 1)

The method of claim 1, wherein mass spectrometry comprises tandem mass spectrometry.

### Claim 6 (depends on 1)

The method of claim 1, wherein said one or more ions comprise an ion with a mass to charge ratio (m/z) of 327.2±0.5.

### Claim 7 (depends on 1)

The method of claim 1, wherein said one or more ions comprise an ion with a mass to charge ratio (m/z) of 301.2±0.5.

### Claim 8 (depends on 1)

The method of claim 1, wherein said sample comprises human serum or plasma.

### Claim 9 (depends on 1)

The method of claim 1, wherein said sample is subjected to a hydrolyzing agent prior to ionization.

### Claim 10 (depends on 8)

The method of claim 8, wherein said hydrolyzing agent is an acid.

### Claim 11 (depends on 1)

The method of claim 1, wherein said one or more omega-3 fatty acids is subjected to liquid/liquid extraction prior to ionization.

### Claim 12 (depends on 1)

The method of claim 1, wherein said one or more omega-3 fatty acids is purified by liquid chromatography prior to ionization.

### Claim 13 (depends on 12)

The method of claim 12, wherein said liquid chromatography comprises high performance liquid chromatography (HPLC).

### Claim 14 (depends on 1)

The method of claim 1, wherein said method comprises determining the amount of an internal standard.

### Claim 15 (depends on 14)

The method of claim 14, wherein said internal standard is a deuterated omega-3 fatty acid.

### Claim 16 (depends on 15)

The method of claim 15, wherein said deuterated omega-3 fatty acid is DHA-2H5.

### Claim 17 (depends on 15)

The method of claim 15, wherein said deuterated omega-3 fatty acid is EPA-2H5.
